Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: A multicenter experience using adipose-derived mesenchymal stem cell therapy for cats with chronic, non-responsive gingivostomatitis

Fig. 4

The proliferative response of PBMCs from FCGS patients prior to and after treatment with ASCs as determined through BrdU incorporation. Sample sizes (n), 3–6 cats for non-responder group and 11–13 cats for responder group; pre, prior to ASC treatment, post, after ASC treatment, D0, day 0; 3M, 3-month follow-up; 6M, 6-month follow-up

Back to article page